SCHEMBL4043116

SCHEMBL4043116

O=C=NC1CC=CCC1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL471716 1.00
SCHEMBL822919 1.00
Methane SCHEMBL2313551 0.98 ALDH1A1 (0.43)
SCHEMBL7591312 0.92 ALDH1A1 (0.39)
SCHEMBL2313556 0.82 LMNA (0.36)
SCHEMBL7231134 0.76 CDK1 (0.37)
SCHEMBL805328 0.73
SCHEMBL433014 0.73
SCHEMBL9935418 0.72 ALDH1A1 (0.39)
SCHEMBL2838737 0.71

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 40 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230295369-A1 A THERMOPLASTIC POLYURETHANE BASED POLYMERIC ELECTROLYTE COMPOSITION HUNTSMAN INTERNATIONAL LLC 2023-09-21 US disclosed
CN-113388317-B Low gloss high solids polyurea coatings 赢创运营有限公司 2022-12-02 CN disclosed
CN-113388317-A Low gloss high solids polyurea coatings 赢创运营有限公司 2021-09-14 CN disclosed
CN-108699211-B Polycarbonamide resins for metal coating applications 赢创运营有限公司 2021-04-16 CN disclosed
WO-2017133667-A1 PYRIMIDINE AND PYRIDINE DERIVATIVES AND USE IN TREATMENT, AMELIORATION OR PREVENTION OF INFLUENZA THEREOF SAVIRA PHARMACEUTICALS GMBH (AT) 2017-08-10 WO disclosed
WO-2017133667-A1 PYRIMIDINE AND PYRIDINE DERIVATIVES AND USE IN TREATMENT, AMELIORATION OR PREVENTION OF INFLUENZA THEREOF SAVIRA PHARMACEUTICALS GMBH (AT) 2017-08-10 WO disclosed
US-9120727-B2 Process for the preparation of pleuromutilins NABRIVA THERAPEUTICS AG (AT) 2015-09-01 US disclosed
US-9120727-B2 Process for the preparation of pleuromutilins NABRIVA THERAPEUTICS AG (AT) 2015-09-01 US disclosed
US-20130079400-A1 PROCESS FOR THE PREPARATION OF PLEUROMUTILINS NABRIVA THERAPEUTICS AG (AT) 2013-03-28 US disclosed
US-20130079400-A1 PROCESS FOR THE PREPARATION OF PLEUROMUTILINS NABRIVA THERAPEUTICS AG (AT) 2013-03-28 US disclosed
EP-0166599-B1 FLUOROCHEMICAL ALLOPHANATE COMPOSITIONS AND FIBROUS SUBSTRATES TREATED THEREWITH MINNESOTA MINING AND MANUFACTURING COMPANY (US) 1990-12-05 EP disclosed
US-4748267-A Fluorochemical biuret compounds and fibrous substrates treated therewith MINNESOTA MINING AND MANUFACTURING COMPANY (US) 1988-05-31 US disclosed
US-4668406-A OIL REPELLENTS, WATERPROOFING, ANTISOILANTS, FLUOROALIPHATIC POLYOXYALKYLENE MINNESOTA MINING AND MANUFACTURING COMPANY (US) 1987-05-26 US disclosed
EP-0166599-A2 Fluorochemical allophanate compositions and fibrous substrates treated therewith MINNESOTA MINING AND MANUFACTURING COMPANY (US) 1986-01-02 EP disclosed
EP-0160402-A2 Fluorochemicals and fibrous substrates treated therewith MINNESOTA MINING AND MANUFACTURING COMPANY (US) 1985-11-06 EP disclosed
EP-0157611-A1 Fluorochemical biuret compositions and fibrous substrates treated therewith MINNESOTA MINING AND MANUFACTURING COMPANY (US) 1985-10-09 EP disclosed
US-4028344-A FOAMING AGENTS, FREE RADICAL INITIATORS PENNWALT CORPORATION (US) 1977-06-07 US disclosed
US-4024128-A HYPOGLYCEMIC AGENTS HOFFMANN-LA ROCHE INC. (US) 1977-05-17 US disclosed
US-3994886-A ANTIBACTERIAL RECHERCHE ET INDUSTRIE THERAPEUTIQUES (R.I.T.) (BE) 1976-11-30 US disclosed
US-3994887-A ANTIBACTERIAL RECHERCHE ET INDUSTRIE THERAPEUTIQUES (R.I.T.) (BE) 1976-11-30 US disclosed